Published in Hepatitis Weekly, August 14th, 1995
However, Hans Vrielink, M.D., and colleagues, Red Cross Blood Transfusion Service, Amsterdam, Netherlands, expressed concern that the use of third-generation ELISAs and immunoblot systems may result in false-positive reactions in a new population of blood donors ("Comparison of Two Anti-Hepatitis C Virus Enzyme-Linked Immunosorbent Assays," Transfusion, July 1995;35(7):601-604).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.